Q3 2025 Holdings
Filed 2025-11-12 | 92 holdings | $248.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Calumet, Inc.(CLMT) | Common | 131428104 | $51.6M | 2,825,231 | 20.8% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $30.0M | 225,000 | 12.1% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $27.3M | 112,220 | 11.0% |
| Janus Henderson AAA CLO ETF(JAAA) | Common | 47103U845 | $22.2M | 437,754 | 9.0% |
| Darling Ingredients Inc.(DAR)Call | Common | 237266101 | $9.3M | 300,000 | 3.7% |
| Xeris Biopharma Holdings, Inc.(XERS) | Common | 98422E103 | $8.3M | 1,015,000 | 3.3% |
| Syndax Pharmaceutical, Inc.(SNDX) | Common | 87164F105 | $6.6M | 428,000 | 2.7% |
| JPMorgan Chase & Co.(JPM) | Common | 46625H100 | $6.4M | 20,374 | 2.6% |
| Travere Therapeutics, Inc.(TVTX) | Common | 89422G107 | $6.2M | 260,000 | 2.5% |
| Avadel Pharmaceuticals plc | Common | G29687103 | $5.5M | 363,000 | 2.2% |
| Protagonist Therapeutics, Inc(PTGX) | Common | 74366E102 | $5.5M | 83,000 | 2.2% |
| Bridgebio Pharma, Inc.(BBIO) | Common | 10806X102 | $4.4M | 85,000 | 1.8% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $4.2M | 3,070,850 | 1.7% |
| Verona Pharma Plc.(VRNA) | Common | 925050106 | $4.1M | 38,355 | 1.7% |
| Lenz Therapeutics, Inc.(LENZ) | Common | 52635N103 | $3.8M | 82,000 | 1.5% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $3.7M | 189,000 | 1.5% |
| Rezolute, Inc.(RZLT) | Common | 76200L309 | $2.6M | 275,000 | 1.0% |
| Viridian Therapeutics, Inc.(VRDN) | Common | 92790C104 | $2.5M | 116,574 | 1.0% |
| CSX Corporation(CSX) | Common | 126408103 | $2.5M | 70,000 | 1.0% |
| Liquidia Corporation(LQDA) | Common | 53635D202 | $2.5M | 107,783 | 1.0% |
| Arcellx Inc(ACLX) | Common | 03940C100 | $2.1M | 25,700 | 0.9% |
| Pfizer Inc.(PFE) | Common | 717081103 | $1.9M | 74,537 | 0.8% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.8M | 48,000 | 0.7% |
| AtriCure, Inc.(ATRC) | Common | 04963C209 | $1.7M | 48,000 | 0.7% |
| Cytokinetics, Incorporated(CYTK) | Common | 23282W605 | $1.6M | 30,000 | 0.7% |
| Ultragenyx Pharmaceutical Inc.(RARE) | Common | 90400D108 | $1.6M | 52,000 | 0.6% |
| Praxis Precision Medicines, Inc.(PRAX) | Common | 74006W207 | $1.5M | 28,000 | 0.6% |
| Arcus Biosciences, Inc.(RCUS) | Common | 03969F109 | $1.3M | 95,200 | 0.5% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $1.3M | 6,922 | 0.5% |
| The Panagram Bbb-B CLO(CLOZ) | Common | 81752T528 | $1.3M | 47,807 | 0.5% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $1.2M | 27,000 | 0.5% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $1.2M | 5,037 | 0.5% |
| Tectonic Therapeutic, Inc.(TECX) | Common | 878972108 | $1.2M | 74,000 | 0.5% |
| Ryman Hospitality Properties, Inc.(RHP) | Common | 78377T107 | $1.1M | 12,000 | 0.4% |
| Solid Bioscience Inc.(SLDB) | Common | 83422E204 | $1.0M | 162,440 | 0.4% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common | 23954D109 | $920.0K | 130,500 | 0.4% |
| Madrigal Pharmaaceuticals, Inc.(MDGL) | Common | 558868105 | $917.3K | 2,000 | 0.4% |
| Microsoft Corporation(MSFT) | Common | 594918104 | $828.7K | 1,600 | 0.3% |
| Cybin Inc(HELP) | Common | 23256X407 | $826.0K | 140,242 | 0.3% |
| Vera Therapeutics, Inc.(VERA) | Common | 92337R101 | $755.6K | 26,000 | 0.3% |
| Corteva, Inc.(CTVA) | Common | 22052L104 | $747.4K | 11,051 | 0.3% |
| Kimberly-Clark Corporation(KMB) | Common | 494368103 | $746.0K | 6,000 | 0.3% |
| DuPont de Nemours, Inc.(DD) | Common | 26614N102 | $733.7K | 9,418 | 0.3% |
| Wave Life Science Ltd.(WVE) | Common | Y95308105 | $658.8K | 90,000 | 0.3% |
| iShares Biotechnology ETF(IBB) | Common | 464287556 | $649.7K | 4,500 | 0.3% |
| Apple Inc.(AAPL) | Common | 037833100 | $635.0K | 2,494 | 0.3% |
| Mereo BioPharm Group PLC(MREO) | Common | 589492107 | $618.7K | 300,337 | 0.2% |
| International Business Machines(IBM) | Common | 459200101 | $604.4K | 2,142 | 0.2% |
| Kura Oncology, Inc.(KURA) | Common | 50127T109 | $595.6K | 67,302 | 0.2% |
| Alkermes PLC(ALKS) | Common | G01767105 | $579.0K | 19,300 | 0.2% |